Recombinant Human XRCC4 Protein ，GST

XRCC4 (X-ray repair cross-complementing protein 4) plays a crucial role in the cellular mechanisms of DNA double-strand break repair, primarily through its function in non-homologous end joining (NHEJ). This process is vital for maintaining genomic stability and preventing mutations that could lead to cancer. Mutations or deficiencies in XRCC4 have been associated with various disorders, including immunodeficiencies and increased cancer susceptibility. Researchers have increasingly focused on XRCC4 due to its involvement in cellular responses to ionizing radiation and its potential as a therapeutic target for enhancing the efficacy of radiation therapy in cancer treatment. The study of XRCC4 recombinant proteins has provided valuable insights into its structural and functional properties, revealing its interaction with other key proteins in the NHEJ pathway, such as DNA ligase IV and the Ku heterodimer. This understanding not only aids in elucidating the fundamental mechanisms of DNA repair but also opens avenues for developing innovative strategies to manipulate this pathway for therapeutic benefits. With advancements in molecular biology techniques, including CRISPR-Cas9 and protein engineering, there is a growing interest in the potential of XRCC4-based therapies, which could enhance DNA repair in various therapeutic contexts or exploit its mechanisms to sensitize cancer cells to treatment. Overall, the research on XRCC4 recombinant proteins continues to be pivotal in advancing our understanding of DNA repair processes and their implications in health and disease.